Global Launch – A New Pharma Initiative takes on the Antibiotic Innovation Challenge (Washington DC)

Washington, D.C. USA

The world is losing its most powerful tool in healthcare: antibiotics. The reason is rapidly rising antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The world needs new antibiotics to stem the toll superbugs are having on patients, but there are few in the pipeline. This is the result of a long-standing paradox: despite the huge societal costs of AMR, there is currently no viable market for new antibiotics. In the long term, the uncontrolled rise of AMR could have public health and economic consequences greater than COVID-19. But unlike COVID-19, AMR is a predictable and preventable crisis – we must take action now.

Launch events on 9 July from Berlin and Washington D.C and on 10 July from Tokyo.

Organized by IFPMA, PhRMA and BIO.

9:00 AM – 10:30AM EDT

Introduction and welcome remarks

David Ricks, Chairman and CEO, Eli Lilly and Company

FIRESIDE CHAT – Patient experience with AMR

Michelle McMurry-Heath, President and CEO, BIO – moderator
Brandon Noble, former NFL player

CEO ROUNDTABLE – Collaborating to beat the public health challenge (followed by Q&A)

Steve Ubl, President and CEO, PhRMA – moderator
Albert Bourla, Chairman and CEO, Pfizer
Ken Frazier, Chairman and CEO, Merck
David Ricks, Chairman and CEO, Eli Lilly and Company

KEYNOTE REMARKS – The world urgently needs new antibiotics: Politics, leadership, and public health

ADM Brett P. Giroir, MD, Assistant Secretary for Health
Senator Bill Cassidy, MD (R-LA)
Senator Bob Casey (D-PA)

PANEL – The AMR ecosystem challenges, opportunities and policies necessary for change (followed by Q&A)

Scott Gottlieb, resident fellow, American Enterprise Institute – moderator
Helen Boucher, MD, board member and treasurer, Infectious Disease Society of America
Michael Boyle, MD, president and CEO, Cystic Fibrosis Foundation
Kevin Outterson, executive director and principal investigator, CARB-X
Kathy Talkington, director, Health Programs, The Pew Charitable Trusts
Ramani Varanasi, founder/president/CEO, X-Biotix

Closing remarks

Ken Frazier, Chairman and CEO, Merck